Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-25 @ 4:23 AM
NCT ID:
NCT01109420
Eligibility Criteria:
* INCLUSION CRITERIA:
Subjects will be selected for this protocol based on either a clinical diagnosis of non-medullary thyroid cancer and the presence of one family member with the disease or the presence of 2 living family members with this disease. Patient selection for this protocol will not be based on gender, race, or ethnic background.
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
* Adults or minor (\>= 7 years+), males and females.
* An unaffected individual with (Bullet) 2 first-degree relatives who have or have had nonmedullary thyroid cancer
OR
-An affected individual with documented diagnosis of non-medullary thyroid cancer and (Bullet) one living relative with documented non-medullary thyroid cancer (Note: as this is a familial study, subjects do not need to present with the disease)
OR
* Any member of an affected family. (Note: for this study, an affected family is defined as a family having 2 or more 1st degree relatives with a documented diagnosis of FNMTC.)
* Adults must be able to understand and the willingness to sign the informed consent document.
* Adults must be able to complete the family history questionnaire.
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be not be allowed to enroll in this study:
-Subjects unwilling/unable to give informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
7 Years
Maximum Age:
90 Years
Study:
NCT01109420
Study Brief:
Protocol Section:
NCT01109420